TRUP - Trupanion, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
33.09
+0.50 (+1.53%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close32.59
Open32.91
Bid31.25 x 1000
Ask37.30 x 1800
Day's Range32.72 - 33.73
52 Week Range20.84 - 37.12
Volume308,676
Avg. Volume296,971
Market Cap1.156B
Beta (3Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • MetLife to Foray Into Pet Insurance Via PetFirst Acquisition
    Zacks

    MetLife to Foray Into Pet Insurance Via PetFirst Acquisition

    MetLife (MET) to acquire PetFirst to enter the rapidly growing pet insurance market.

  • American City Business Journals

    This is what workers earn at some of Washington's largest public companies

    It's only the second year median worker pay disclosures have been required, and not all the more than 70 public companies in Washington state have released those figures.

  • Will Trupanion Continue to Surge Higher?
    Zacks

    Will Trupanion Continue to Surge Higher?

    As of late, it has definitely been a great time to be an investor Trupanion.

  • Trupanion, Inc. (NASDAQ:TRUP) Insiders Have Been Selling
    Simply Wall St.

    Trupanion, Inc. (NASDAQ:TRUP) Insiders Have Been Selling

    It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...

  • Aflac Acquires Argus, Expands U.S. Segment Product Suite
    Zacks

    Aflac Acquires Argus, Expands U.S. Segment Product Suite

    Aflac's (AFL) acquisition of Argus equips it to provide Dental and Vision products to customers in the United States.

  • Thomson Reuters StreetEvents

    Edited Transcript of TRUP earnings conference call or presentation 5-Nov-19 9:30pm GMT

    Q3 2019 Trupanion Inc Earnings Call

  • Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates
    Zacks

    Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates

    Trupanion (TRUP) delivered earnings and revenue surprises of 200.00% and 1.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for

    Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Is Trupanion Inc (TRUP) Going To Burn These Hedge Funds ?
    Insider Monkey

    Is Trupanion Inc (TRUP) Going To Burn These Hedge Funds ?

    Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition to our portfolios. The odds are not exactly stacked in investors' favor when it comes to beating the market, […]

  • Before You Buy Trupanion, Inc. (NASDAQ:TRUP), Consider Its Volatility
    Simply Wall St.

    Before You Buy Trupanion, Inc. (NASDAQ:TRUP), Consider Its Volatility

    If you're interested in Trupanion, Inc. (NASDAQ:TRUP), then you might want to consider its beta (a measure of share...

  • Thomson Reuters StreetEvents

    Edited Transcript of TRUP earnings conference call or presentation 30-Jul-19 8:30pm GMT

    Q2 2019 Trupanion Inc Earnings Call

  • Trupanion, Inc. (NASDAQ:TRUP): Is Breakeven Near?
    Simply Wall St.

    Trupanion, Inc. (NASDAQ:TRUP): Is Breakeven Near?

    Trupanion, Inc.'s (NASDAQ:TRUP): Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats...

  • Tom Gayner Buys 6 Stocks in 2nd Quarter
    GuruFocus.com

    Tom Gayner Buys 6 Stocks in 2nd Quarter

    Guru’s largest new position is Bank of New York Mellon Continue reading...

  • Trupanion's Spending a Lot More to Get Pets Into Its Ecosystem
    Motley Fool

    Trupanion's Spending a Lot More to Get Pets Into Its Ecosystem

    But growth was still solid. How does it all balance out?

  • Trupanion Inc (TRUP) Q2 2019 Earnings Call Transcript
    Motley Fool

    Trupanion Inc (TRUP) Q2 2019 Earnings Call Transcript

    TRUP earnings call for the period ending June 30, 2019.

  • Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates
    Zacks

    Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates

    Trupanion (TRUP) delivered earnings and revenue surprises of -100.00% and 1.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • If You Had Bought Trupanion (NASDAQ:TRUP) Shares Five Years Ago You'd Have Made 197%
    Simply Wall St.

    If You Had Bought Trupanion (NASDAQ:TRUP) Shares Five Years Ago You'd Have Made 197%

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...

  • Here’s What Hedge Funds Think About Trupanion Inc (TRUP)
    Insider Monkey

    Here’s What Hedge Funds Think About Trupanion Inc (TRUP)

    Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the […]

  • 2 Stocks to Play the Pet Care Trend
    Motley Fool

    2 Stocks to Play the Pet Care Trend

    With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.

  • 3 Top Insurance Stocks to Buy Now
    Motley Fool

    3 Top Insurance Stocks to Buy Now

    These insurers could produce excellent returns in the coming years.

  • ETF Trends

    Inside The Potential Potency of Pet Stocks

    The ProShares Pet Care ETF (CBOE:PAWZ) debuted last November as the first exchange traded fund (ETF) dedicated to the pet care industry and related investment opportunities. While PAWZ does not have a lengthy track record, it is already proving to be a durable ETF amid increased equity market volatility. Last month, the S&P 500 slid 5.67%, but PAWZ lost just 1.51%.

  • How Much is Trupanion, Inc.'s (NASDAQ:TRUP) CEO Getting Paid?
    Simply Wall St.

    How Much is Trupanion, Inc.'s (NASDAQ:TRUP) CEO Getting Paid?

    Darryl Graham Rawlings has been the CEO of Trupanion, Inc. (NASDAQ:TRUP) since 2000. This analysis aims first to...

  • InvestorPlace

    You Can Get Buy Signals From Short Selling

    You may be surprised to hear this, but a large amount of short interest in a stock could actually be a buy signal.What is short selling a stock? It's selling a stock that you don't own with the intention of buying it back at a lower price in the future, usually using options. And short interest is the number of shares that are sold short that haven't been bought back yet. It is usually expressed as a ratio of shares that are short to the total number of outstanding shares.The short interest can also be expressed as "Days to Cover." This is the number of short shares divided by the average daily trading volume. In other words, it is the number of days that it would take for all the short shares to be bought back.InvestorPlace - Stock Market News, Stock Advice & Trading TipsI should note, this number should be considered understated, because it assumes purchasing 100% of the volume. This would be impossible in normal markets. It would be more realistic to assume that short sellers could only buy about 10%-15% of the average daily volume with adversely affecting the price. * 7 Safe Stocks to Buy for Anxious Investors You should pay attention to this because really high short-interest could be a bullish signal. This is because these shares need to be bought back. These short-sellers will all eventually become buyers! Trupanion (TRUP)Trupanion (NASDAQ:TRUP) provides medical insurance for cats and dogs. It has a subscription business and also offers insurance to companies that can provide it as a benefit to their employees.There are about 11.2 million shares currently short. This is 38% of the outstanding float. The average daily volume recently is about 145,000. That means the days to cover would be about 77. And remember, that assumes buying 100% of the volume.It would be more realistic to assume that one could only trade about 10% of the volume without adversely affecting the price. That means it could take years for the shorts to cover all of their positions!Wall Street seems to disagree with the shorts. Six firms follow it and the all have buy ratings on it. The average price target is $40. Accelerate Diagnostics (AXDX)Accelerate Diagnostics (NASDAQ:AXDX) engages in developing and selling instruments that are used to fight infectious pathogens.There are 14.1 million shares currently short in this company. That is 52% of the float. That means that there are guaranteed buyers for about half of the company's stock! Assuming that they buy 10% of the average daily volume, it would take about two years to cover it. * 7 Stocks to Buy for Over 20% Upside Potential All four of the analysts who cover this have a buy rating on it according to Yahoo Finance. OptiNose (OPTN)OptiNose (NASDAQ:OPTN) develops and sells products that are for the treatment of ear, nose, throat and allergy illnesses.The short-interest is 7.9 million, or about 49% of the float. Over the past year, the price of the stock has fallen from $30 to current levels around $9.Wall Street doesn't feel as bad about this company's prospects as the short sellers do. It likes this stock. All four analysts that follow it have it rated as a buy and the average target price is $25. That is about three times higher then where it is currently trading. Energy Recovery (ERII)Energy Recovery (NASDAQ:ERII) develops and sells products that are for industrial fluid flow application. Their customers include oil and gas companies.5.5 million shares are currently short. That is about 14% of the float. It isn't as much as the other companies, but it is still pretty high. It only trades about 112,000 on a typical day, so that would give a days to cover number of about 50. Using our estimate of being able to only acquire about 10%-15% of the volume that trades with adversely affecting the price, it would take over a year to cover. * 7 High-Yield REITs to Buy (Even When the Market Tanks) There are six buys on this company. The average target price is about $16, which is about 60% above current prices. Seres Therapeutics (MCRB)Seres Therapeutics (NASDAQ:MCRB) creates medicines "using live bacteria to treat diseases that result from functional deficiencies in the microbiome."The share price fell dramatically over the past month. The current short interest is 5.3 million of the float. That is about 25%. With an average daily volume of about 111,000, the days to cover is 48.This company is followed by nine Wall Street firms. Seven have it rated as a buy and the other two have it as a hold. The average target price is $11 and it is currently trading below $5. Theravance Biopharma (TBPH)Theravance Biopharma (NASDAQ:TBPH) is a biopharmaceutical company. It focuses and the research, development and commercialization of small molecule medicines.The short-interest ratio here is "only" 15%, or 6.3 million shares. The stock only trades about 154,000 shares on a typical day, so that is 41 days to cover.Remember, it is safe to assume that they can buy about 10% of the volume without adversely affecting the price. * 6 Chinese Stocks That Could Pop On a Trade Deal Seven firms follow this company. Four of them have it rated a buy and three have it as a sell. The average target price is just over $38 per share.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Safe Stocks to Buy for Anxious Investors * 4 Tech Stocks Looking Vulnerable * Should You Buy, Sell, Or Hold These 7 Hot IPO Stocks? Compare Brokers The post You Can Get Buy Signals From Short Selling appeared first on InvestorPlace.